找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Acute Promyelocytic Leukemia; A Clinical Guide Oussama Abla,Francesco Lo Coco,Miguel A. Sanz Book 2018 Springer International Publishing AG

[復制鏈接]
樓主: 揭發(fā)
51#
發(fā)表于 2025-3-30 08:16:16 | 只看該作者
52#
發(fā)表于 2025-3-30 15:04:44 | 只看該作者
Inferences from Statistics to Causationrobably benefit from prolonged application of ATO. Even after frontline therapy with ATO, salvage therapy with ATO may still be effective. This chapter gives an overview on the currently available treatment options for relapsed APL, as well as on prognostic factors, which may influence the relapse management in the individual patient.
53#
發(fā)表于 2025-3-30 18:29:24 | 只看該作者
Causation, Laws and Regularitiesat diagnosis has been utilized to distinguish two risk groups (standard and high risk) on recent pediatric clinical trials to allow risk-adapted therapy. Current research efforts focus on the incorporation of ATO into treatment regimens and further defining risk factors for early death and relapse.
54#
發(fā)表于 2025-3-30 21:31:52 | 只看該作者
55#
發(fā)表于 2025-3-31 00:50:59 | 只看該作者
56#
發(fā)表于 2025-3-31 05:16:28 | 只看該作者
https://doi.org/10.1007/978-3-031-59135-8causative role in APL pathogenesis [1]. The gene fusion is readily detectable at diagnosis with sensitive PCR techniques and is an extremely reliable target to monitor the residual disease at the molecular level. We will discuss the evolution and importance of minimal residual disease (MRD) monitoring in APL.
57#
發(fā)表于 2025-3-31 09:18:30 | 只看該作者
58#
發(fā)表于 2025-3-31 16:18:10 | 只看該作者
Mary Jean Walker,Wendy A. Rogersderived compounds, all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO). The efficacy of these two agents against the disease and their synergistic and curative potential was predicted by transgenic murine models, which were equally instrumental in unlocking the molecular pathogenesis of APL.
59#
發(fā)表于 2025-3-31 18:53:26 | 只看該作者
60#
發(fā)表于 2025-4-1 01:34:58 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 17:57
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
台北市| 平陆县| 辛集市| 丹巴县| 崇州市| 青川县| 钟祥市| 双鸭山市| 江安县| 竹北市| 资兴市| 乌拉特中旗| 东辽县| 新竹县| 吉水县| 乳源| 平顶山市| 泌阳县| 宁蒗| 垦利县| 牡丹江市| 扶绥县| 太谷县| 新乡市| 裕民县| 安平县| 新化县| 仙居县| 革吉县| 台山市| 黔西县| 文化| 福海县| 屏东市| 平乡县| 鸡东县| 屏山县| 咸宁市| 黄平县| 林周县| 科技|